ENVIOMYCIN SULFATE

Details

Stereochemistry	ABSOLUTE
Molecular Formula	2C25H43N13O10.3H2O4S
Molecular Weight	1665.615
Optical Activity	UNSPECIFIED
Defined Stereocenters	14 / 14
E/Z Centers	2
Charge	0

SHOW SMILES / InChI

Structure Search

SMILES

OS(O)(=O)=O.OS(O)(=O)=O.OS(O)(=O)=O.[H][C@@]1(CCNC(=N)N1)[C@]2([H])NC(=O)\C(NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@H](CNC2=O)NC(=O)C[C@@H](N)[C@H](O)CCN)=C\NC(N)=O.[H][C@@]3(CCNC(=N)N3)[C@]4([H])NC(=O)\C(NC(=O)[C@H](CO)NC(=O)[C@H](CO)NC(=O)[C@H](CNC4=O)NC(=O)C[C@@H](N)[C@H](O)CCN)=C\NC(N)=O

InChI

InChIKey=DZKQVWCTFCSEKF-QOEBQMAPSA-N

InChI=1S/2C25H43N13O10.3H2O4S/c2*26-3-1-16(41)10(27)5-17(42)33-12-6-31-23(47)18(11-2-4-30-24(28)37-11)38-20(44)13(7-32-25(29)48)34-21(45)14(8-39)36-22(46)15(9-40)35-19(12)43;3*1-5(2,3)4/h2*7,10-12,14-16,18,39-41H,1-6,8-9,26-27H2,(H,31,47)(H,33,42)(H,34,45)(H,35,43)(H,36,46)(H,38,44)(H3,28,30,37)(H3,29,32,48);3*(H2,1,2,3,4)/b2*13-7-;;;/t2*10-,11-,12+,14+,15+,16-,18+;;;/m11.../s1

HIDE SMILES / InChI

Description
Sources: https://www.ncbi.nlm.nih.gov/pubmed/4308717
Curator's Comment: description was created based on several sources, including: https://www.ncbi.nlm.nih.gov/pubmed/2539957 | https://www.ncbi.nlm.nih.gov/pubmed/17571483

Enviomycin, antimicrobial drug, was isolated in Japan from fermentation broth of Syteptomyces griseoverticillatus var tuberacticus. This drug, a water-soluble, basic peptide, is effective against tubercle bacilli as well as some gram-positive and gram-negative bacteria. It is related to viomycin and cepreomycin in some of its physicochemical properties. It is used for the treatment of Mycobacterium avium caused lung diseases.

Originator

Approval Year

Targets

Primary Target	Pharmacology	Condition	Potency
Group I intron splicing 2 Target ID: GO:0000372 Sources: https://www.ncbi.nlm.nih.gov/pubmed/7509881	Inhibitor 8297

Conditions

Condition	Modality	Targets	Highest Phase	Product
Tuberculosis 83 Sources: https://www.ncbi.nlm.nih.gov/pubmed/6276611 https://www.ncbi.nlm.nih.gov/pubmed/2539957	Curative		Not Provided 504	Unknown Approved Use Unknown

PubMed

Title	Date	PubMed
[A case of pulmonary Mycobacterium fortuitum infection successfully treated with Kampo treatments].	2006 Aug	16972656
[Case of multi-drug resistant pulmonary tuberculosis with bilateral cavitary lesions successfully treated by surgical treatment].	2007 Nov	18078108

Patents

Sample Use Guides

In Vivo Use Guide

1 g/day three times weekly

Route of Administration: Unknown

In Vitro Use Guide

Enviomycin is bactericidal against Mycobacterium avium strain 13887 with MIC=1.6 ug/ml.

Name

Type

Language

ENVIOMYCIN SULFATE

Common Name

English

ENVIOMYCIN SULFATE [MI]

Common Name

English

TUBERACTIN

Brand Name

English

Enviomycin sulfate [WHO-DD]

Common Name

English

ENVIOMYCIN SULFATE [JAN]

Common Name

English

VIOMYCIN, 1-((3R,4R)-4-HYDROXY-3,6-DIAMINOHEXANOIC ACID)-6-(L-2-(2-AMINO-1,4,5,6-TETRAHYDRO-4-PYRIMIDINYL)GLYCINE)-, (R)-, SULFATE (2:3) (SALT)

Common Name

English

CYCLO((2Z)-3-((AMINOCARBONYL)AMINO)-2,3-DIDEHYDROALANYL-(2S)-2-((4R)-2-AMINO-3,4,5,6-TETRAHYDRO-4-PYRIMIDINYL)GLYCYL-(2S)-2-(((3R,4R)-3,6-DIAMINO-4-HYDROXY-1-OXOHEXYL)AMINO)-.BETA.-ALANYL-L-SERYL-L-SERYL), SULFATE (2:3)

Code

English

Code System Code Type Description

ChEMBL

CHEMBL2146142